These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 24685231)

  • 1. β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis.
    Raschi E; Chighizola CB; Grossi C; Ronda N; Gatti R; Meroni PL; Borghi MO
    J Autoimmun; 2014 Dec; 55():42-50. PubMed ID: 24685231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells.
    Borghi MO; Raschi E; Grossi C; Chighizola CB; Meroni PL
    Lupus; 2014 Oct; 23(12):1302-4. PubMed ID: 25228733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4.
    Laplante P; Fuentes R; Salem D; Subang R; Gillis MA; Hachem A; Farhat N; Qureshi ST; Fletcher CA; Roubey RA; Merhi Y; Thorin É; Levine JS; Mackman N; Rauch J
    Lupus; 2016 Feb; 25(2):162-76. PubMed ID: 26391610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
    Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
    Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.
    Gharavi AE; Pierangeli SS; Colden-Stanfield M; Liu XW; Espinola RG; Harris EN
    J Immunol; 1999 Sep; 163(5):2922-7. PubMed ID: 10453040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies.
    Pierangeli SS; Vega-Ostertag ME; Raschi E; Liu X; Romay-Penabad Z; De Micheli V; Galli M; Moia M; Tincani A; Borghi MO; Nguyen-Oghalai T; Meroni PL
    Ann Rheum Dis; 2007 Oct; 66(10):1327-33. PubMed ID: 17261530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. oxLDL/β2GPI/anti-β2GPI complex induced macrophage differentiation to foam cell involving TLR4/NF-kappa B signal transduction pathway.
    Xu Y; Kong X; Zhou H; Zhang X; Liu J; Yan J; Xie H; Xie Y
    Thromb Res; 2014 Aug; 134(2):384-92. PubMed ID: 24882274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mechanism of oxLDL/β2GPI/anti-β2GPI antibody complex promoting the expression of adhesion molecules in HUVECs].
    Zhang G; Zhou H; He C; Chen Y; Ouyang H; Zhang P; Wang R
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Nov; 33(11):1472-1478. PubMed ID: 29268849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
    Ostertag MV; Liu X; Henderson V; Pierangeli SS
    Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway.
    Betapudi V; Lominadze G; Hsi L; Willard B; Wu M; McCrae KR
    Blood; 2013 Nov; 122(23):3808-17. PubMed ID: 23954892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Toll-like receptor 4 on β2-glycoprotein I-induced B cell activation in mouse model.
    Cheng S; He C; Zhou H; Kong X; Xie H; Xia L; Yan J
    Mol Immunol; 2016 Mar; 71():78-86. PubMed ID: 26872007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
    Pierangeli SS; Harris EN
    Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis: Report of a family with multiple anti-phospholipid positive members.
    De Angelis V; Scurati S; Raschi E; Liutkus A; Belot A; Borghi MO; Meroni PL; Cimaz R
    J Autoimmun; 2009 Feb; 32(1):60-3. PubMed ID: 19108989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype.
    Meroni PL; Raschi E; Testoni C; Tincani A; Balestrieri G; Molteni R; Khamashta MA; Tremoli E; Camera M
    Arthritis Rheum; 2001 Dec; 44(12):2870-8. PubMed ID: 11762948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome.
    Blank M; Baraam L; Eisenstein M; Fridkin M; Dardik R; Heldman Y; Katchalski-Katzir E; Shoenfeld Y
    J Autoimmun; 2011 Aug; 37(1):8-17. PubMed ID: 21524885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-β2GPI/β2GPI stimulates activation of THP-1 cells through TLR4/MD-2/MyD88 and NF-κB signaling pathways.
    Zhou H; Sheng L; Wang H; Xie H; Mu Y; Wang T; Yan J
    Thromb Res; 2013; 132(6):742-9. PubMed ID: 24157085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-β
    Virachith S; Saito M; Watanabe Y; Inoue K; Hoshi O; Kubota T
    Clin Exp Immunol; 2019 Feb; 195(2):167-178. PubMed ID: 30368780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Toll-like receptor 4 on β2-glycoprotein I-induced splenic T cell subsets differentiation.
    He C; Zhang G; Zhou H; Cheng S; Farwa A
    Immunol Lett; 2018 Jun; 198():17-25. PubMed ID: 29601942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies.
    Meroni PL; Raschi E; Testoni C; Parisio A; Borghi MO
    Autoimmun Rev; 2004 Nov; 3(7-8):510-5. PubMed ID: 15546799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.